SCHEMBL13620960

SCHEMBL13620960

c1ccc(-c2c3ccccc3c(-c3cccc(-c4nc5ccccc5o4)c3)c3ccccc23)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 10/20 0.51
ALDH1A1 P00352 7/20 0.51
HPGD P15428 7/20 0.51
HSD17B10 Q99714 6/20 0.51
MEN1 O00255 4/20 0.51
KMT2A Q03164 4/20 0.51
MAPT P10636 4/20 0.51
USP2 O75604 3/20 0.51
TDP1 Q9NUW8 1/20 0.51
SMN1; SMN2 Q16637 7/20 0.51
TP53 P04637 4/20 0.51
PKM P14618 1/20 0.51
NPC1 O15118 7/20 0.50
RAB9A P51151 5/20 0.50
ATM Q13315 1/20 0.50
CASP3 P42574 3/20 0.49
SENP7 Q9BQF6 3/20 0.49
SENP6 Q9GZR1 3/20 0.49
SENP8 Q96LD8 2/20 0.49
HCRTR1 O43613 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22955745 0.98 KDM4E (0.50) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL13620984 0.93 NPC1 (0.54) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL21250826 0.92 TP53 (0.53) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL13620961 0.91 NPC1 (0.51) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL22956112 0.91 TP53 (0.47) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL21250782 0.91 TP53 (0.47) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL13872550 0.90 NPC1 (0.54) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL21250810 0.89 TP53 (0.48) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL1925604 0.89 NPC1 (0.63) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL18999518 0.89 NPC1 (0.49) KDM4EALDH1A1HPGDHSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8859108-B2 Benzoxazole derivative, and light-emitting element, light-emitting device, and electronic device using the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-10-14 US disclosed
US-8859108-B2 Benzoxazole derivative, and light-emitting element, light-emitting device, and electronic device using the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-10-14 US disclosed
US-20090286985-A1 Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using the Same SEMICONDUCTOR ENERGY LABARATORY CO., LTD. 2009-11-19 US disclosed
US-20090286985-A1 Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using the Same SEMICONDUCTOR ENERGY LABARATORY CO., LTD. 2009-11-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090286985-A1 Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using the Same CYP4X1, XDH, GABRA5 KDM4E 2877/4885ALDH1A1 169/4885HPGD 700/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.